BVF I GP LLC

Related Filers (35)

Ownership (127)

3
Friday, 1/26/2024
Allakos Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/9/2024
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/20/2023
POINT Biopharma Global Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/17/2023
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 11/13/2023
enGene Holdings Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/6/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 11/6/2023
POINT Biopharma Global Inc.: Initial statement of beneficial ownership of securities
4
Friday, 11/3/2023
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/14/2023
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/28/2023
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/21/2023
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
3
Monday, 5/22/2023
PIERIS PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Friday, 5/19/2023
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Friday, 5/12/2023
Structure Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/9/2023
Eledon Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/7/2023
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
3
Monday, 2/13/2023
Structure Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/19/2023
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/13/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/9/2023
XOMA Corp: Statement of changes in beneficial ownership of securities
3
Thursday, 12/22/2022
Third Harmonic Bio, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/22/2022
Third Harmonic Bio, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/10/2022
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/27/2022
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2022
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/23/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/11/2022
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
3
Thursday, 7/21/2022
ESSA Pharma Inc.: Initial statement of beneficial ownership of securities
3
Monday, 6/27/2022
4D Molecular Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/17/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/31/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/24/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Monday, 5/16/2022
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/9/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 4/15/2022
MoonLake Immunotherapeutics: Initial statement of beneficial ownership of securities
4
Tuesday, 4/5/2022
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/11/2022
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
3
Monday, 2/7/2022
Verastem, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 1/31/2022
Eledon Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 1/31/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/26/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/10/2022
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 1/10/2022
Cullinan Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/2/2021
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 11/8/2021
Repare Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Friday, 10/8/2021
Merus N.V.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/23/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/15/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/7/2021
Merus N.V.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/6/2021
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/6/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/26/2021
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/25/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/21/2021
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4/A
Monday, 5/17/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/17/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/27/2021
Rain Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 4/27/2021
Rain Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/5/2021
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
4
Friday, 4/2/2021
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 4/1/2021
Merus N.V.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/24/2021
Merus N.V.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/18/2021
Merus N.V.: Statement of changes in beneficial ownership of securities
4
Friday, 3/12/2021
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
3
Monday, 3/8/2021
FIVE PRIME THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Friday, 2/19/2021
INFINITY PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
CytomX Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/16/2021
INFINITY PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/4/2021
IDEAYA Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
INFINITY PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 1/25/2021
Merus N.V.: Statement of changes in beneficial ownership of securities
3
Monday, 12/28/2020
CytomX Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 12/28/2020
Eledon Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/22/2020
Merus N.V.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/15/2020
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Friday, 12/11/2020
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
3
Friday, 12/4/2020
CYTOKINETICS INC: Initial statement of beneficial ownership of securities
4
Friday, 11/20/2020
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/20/2020
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
3
Thursday, 11/19/2020
Olema Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 11/16/2020
CYTOKINETICS INC: Initial statement of beneficial ownership of securities
4
Friday, 11/13/2020
FIVE PRIME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 11/6/2020
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 11/6/2020
FIVE PRIME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/3/2020
GLYCOMIMETICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2020
FIVE PRIME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 10/5/2020
Novus Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 9/24/2020
FIVE PRIME THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/23/2020
XOMA Corp: Statement of changes in beneficial ownership of securities
Show More